Opinion

Video

Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations

Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.

Video content above is prompted by the following:

What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Sundar Jagannath
4 experts in this video
4 experts in this video
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com
2 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo